Lyophilization removes water under low temperature and vacuum, which helps preserve peptide stability during storage
Use immediately or store aliquots at -80C
Is AHK-Cu for human consumption
Each vial holds up to 3 ml of bacteriostatic water
useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established

Current Research Areas Musculoskeletal, tendon, ligament, and connective tissue research Angiogenesis and microvascular function studies Fibroblast and endothelial cell migration research Inflammatory signaling and cytokine pathway investigations Wound healing and extracellular matrix remodeling studies Additionally, researchers continue to evaluate this peptide blend in laboratory models that explore coordinated tissue repair and cellular response